Bullous systemic lupus erythematosus with lupus nephritis: A rare case of a subepidermal bullous disorder in a child

Cutis

Volumn 89, Issue 1, 2012, Pages 17-21

  Poojary, Shital ^a   Rais, Sama ^a  

^a K J Somaiya Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G; PREDNISOLONE;

ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PREDNISOLONE; SKIN DISEASES, VESICULOBULLOUS;

EID: 84860130318     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Vassileva S. Bullous systemic lupus erythematosus. Clin Dermatol. 2004;22:129-138.
2. Shirahama S, Furukawa F, Yagi H, et al. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. J Am Acad Dermatol. 1998;38(5, pt 2):844-848.
3. Yell JA, Allen J, Wojnarowska F, et al. Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br J Dermatol. 1995;132:921-928.
4. Pedro SD, Dahl MV. Direct immunofluorescence of bullous systemic lupus erythematosus. Arch Dermatol. 1973;107:118-120.
5. Burge S, Shomberg K, Wojnarowska F. Bullous eruption of SLE-a case report and investigation of the relationship of anti-basement-membrane-zone antibodies to blistering. Clin Exp Dermatol. 1991;16:133-138.
6. Condon C, Phelan M, Lyons JF. Penicillamine-induced type II bullous systemic lupus erythematosus. Br J Dermatol. 1997;136:474-475.
7. Fleming MG, Bergfeld WF, Tomecki KJ, et al. Bullous systemic lupus erythematosus. Int J Dermatol. 1989;28: 321-326.
8. Chan LS, Lapiere JC, Chen M, et al. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol. 1999;135:569-573.
9. Rappersberger K, Tschachler E, Tani M, et al. Bullous disease in systemic lupus erythematosus. J Am Acad Dermatol. 1989;21(4, pt 1):745-752.
10. Camisa C, Sharma HM. Vesiculobullous systemic lupus erythematosus. report of two cases and a review of the literature. J Am Acad Dermatol. 1983;9:924-933.
11. Camisa C, Grimwood RE. Indirect immunofluorescence in vesiculobullous eruption of systemic lupus erythematosus [letter]. J Invest Dermatol. 1986;86:606.
12. Gammon WR, Briggaman RA. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol. 1993;100:28S-34S.
13. Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998;110:103-109.
14. Weening VD, D'Agati JJ, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Am Soc Nephrol. 2004;15:241-250.